<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39452786</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-0817</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>Pathogens (Basel, Switzerland)</Title><ISOAbbreviation>Pathogens</ISOAbbreviation></Journal><ArticleTitle>Interleukin-1 Beta rs16944 and rs1143634 and Interleukin-6 Receptor rs12083537 Single Nucleotide Polymorphisms as Potential Predictors of COVID-19 Severity.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">915</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/pathogens13100915</ELocationID><Abstract><AbstractText>Host genetic variation has been recognized as a key predictor of diverse clinical sequelae among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected patients. Insights into the link between the Interleukin-6 receptor (IL-6R) and Interleukin-1 beta (IL-1β) genetic variation and severe coronavirus disease 2019 (COVID-19) are crucial for developing new predictors and therapeutic targets. We aimed to investigate the association of IL-6R rs12083537, IL-1β rs16944, and IL-1β rs1143634 SNPs with the severity of COVID-19. Our study was conducted on 300 COVID-19-negative individuals (control group) and 299 COVID-19-positive cases, classified into mild, moderate, and severe subgroups. Analyses of IL-1β (rs16944, rs1143634) and IL-6R (rs12083537) SNPs' genotypes were performed using qPCR genotyping assays. The IL-1β (rs16944) CC genotype and IL-6R (rs12083537) GG genotype were substantially related to COVID-19 severity, which was also associated with comorbidities and some laboratory parameters (<i>p</i> &lt; 0.001). The IL-1β (rs1143634) TT genotype was found to be protective. Likewise, the IL-1β (rs16944) CC genotype was associated with increased mortality. IL-1β rs16944 and IL-6R rs12083537 SNPs are promising potential predictors of SARS-CoV-2 disease severity. Meanwhile, the rs1143634 SNP T allele was protective against severity and mortality risk.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Inas A</ForeName><Initials>IA</Initials><Identifier Source="ORCID">0000-0001-8518-3827</Identifier><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Benha University, Benha 13518, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Central Laboratory for Research, Faculty of Medicine, Benha University, Benha 13518, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Benha National University, El-Obour 11828, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kharboush</LastName><ForeName>Taghrid G</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Immunology, Faculty of Medicine, Benha University, Benha 13518, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Amodi</LastName><ForeName>Hiba S</ForeName><Initials>HS</Initials><Identifier Source="ORCID">0000-0003-1865-0004</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Medicine, Umm Al-Qura University, P.O. Box 715, Makkah 21955, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamel</LastName><ForeName>Hala F M</ForeName><Initials>HFM</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Medicine, Umm Al-Qura University, P.O. Box 715, Makkah 21955, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darwish</LastName><ForeName>Ehab</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-5063-2792</Identifier><AffiliationInfo><Affiliation>Department of Tropical Medicine, Faculty of Medicine, Zagazig University, Zagazig 44511, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Faculty of Medicine, King Faisal University, AI-Ahsa 31982, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosbeh</LastName><ForeName>Asmaa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pathology, National Liver Institute, Menoufia University, Menoufia 32511, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galbt</LastName><ForeName>Hossam A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Department of Clinical Pathology, National Liver Institute, Menoufia University, Menoufia 32511, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdel-Kareim</LastName><ForeName>Amal M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Zoology, Faculty of Science, Benha University, Benha 13518, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelsattar</LastName><ForeName>Shimaa</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3993-5378</Identifier><AffiliationInfo><Affiliation>Department of Clinical Biochemistry and Molecular Diagnostics, National Liver Institute, Menoufia University, Menoufia 32511, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pathogens</MedlineTA><NlmUniqueID>101596317</NlmUniqueID><ISSNLinking>2076-0817</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SNPs</Keyword><Keyword MajorTopicYN="N">genotype</Keyword><Keyword MajorTopicYN="N">interleukin-1 beta</Keyword><Keyword MajorTopicYN="N">interleukin-6 receptor</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>10</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39452786</ArticleId><ArticleId IdType="pmc">PMC11510688</ArticleId><ArticleId IdType="doi">10.3390/pathogens13100915</ArticleId><ArticleId IdType="pii">pathogens13100915</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dhama K., Khan S., Tiwari R., Sircar S., Bhat S., Malik Y.S., Singh K.P., Chaicumpa W., Bonilla-Aldana D.K., Rodriguez-Morales A.J. Coronavirus Disease 2019-COVID-19. Clin. Microbiol. Rev. 2020;33:10–1128. doi: 10.1128/CMR.00028-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00028-20</ArticleId><ArticleId IdType="pmc">PMC7405836</ArticleId><ArticleId IdType="pubmed">32580969</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashour H.M., Elkhatib W.F., Rahman M.M., Elshabrawy H.A. Insights into the recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks. Pathogens. 2020;9:186. doi: 10.3390/pathogens9030186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens9030186</ArticleId><ArticleId IdType="pmc">PMC7157630</ArticleId><ArticleId IdType="pubmed">32143502</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J.-J., Dong X., Liu G.-H., Gao Y.-D. Risk and protective factors for COVID-19 morbidity, severity, and mortality. Clin. Rev. Allergy Immunol. 2023;64:90–107. doi: 10.1007/s12016-022-08921-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-022-08921-5</ArticleId><ArticleId IdType="pmc">PMC8767775</ArticleId><ArticleId IdType="pubmed">35044620</ArticleId></ArticleIdList></Reference><Reference><Citation>Lek M., Karczewski K.J., Minikel E.V., Samocha K.E., Banks E., Fennell T., O’Donnell-Luria A.H., Ware J.S., Hill A.J., Cummings B.B. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–291. doi: 10.1038/nature19057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature19057</ArticleId><ArticleId IdType="pmc">PMC5018207</ArticleId><ArticleId IdType="pubmed">27535533</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdulla Z.A., Al-Bashir S.M., Alzoubi H., Al-Salih N.S., Aldamen A.A., Abdulazeez A.Z. The Role of Immunity in the Pathogenesis of SARS-CoV-2 Infection and in the Protection Generated by COVID-19 Vaccines in Different Age Groups. Pathogens. 2023;12:329. doi: 10.3390/pathogens12020329.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens12020329</ArticleId><ArticleId IdType="pmc">PMC9967364</ArticleId><ArticleId IdType="pubmed">36839601</ArticleId></ArticleIdList></Reference><Reference><Citation>Ovsyannikova I.G., Haralambieva I.H., Crooke S.N., Poland G.A., Kennedy R.B. The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity. Immunol. Rev. 2020;296:205–219. doi: 10.1111/imr.12897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12897</ArticleId><ArticleId IdType="pmc">PMC7404857</ArticleId><ArticleId IdType="pubmed">32658335</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvamani S., Tan H., Thang W., Ter H., Wan M., Gunasekaran B., Rhodes A. Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control. Br. J. Biomed. Sci. 2020;77:168–184. doi: 10.1080/09674845.2020.1826136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09674845.2020.1826136</ArticleId><ArticleId IdType="pubmed">32942955</ArticleId></ArticleIdList></Reference><Reference><Citation>QinC Z. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin. Infect. Dis. 2020;71:762–768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinarello C.A. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol. Rev. 2018;281:8–27. doi: 10.1111/imr.12621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12621</ArticleId><ArticleId IdType="pmc">PMC5756628</ArticleId><ArticleId IdType="pubmed">29247995</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Z.-L., Lin Q.-R., Hu Y.-J., Hou Y.-L., Ma Y.-F., Yu B., Jiang N. Interleukin-1 beta gene polymorphism rs16944 may associate with increased susceptibility to extremity chronic osteomyelitis in Chinese han population. BioMed Res. Int. 2019;2019:7483537. doi: 10.1155/2019/7483537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/7483537</ArticleId><ArticleId IdType="pmc">PMC6425336</ArticleId><ArticleId IdType="pubmed">30949508</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiménez-Sousa M.Á., Medrano L.M., Liu P., Almansa R., Fernández-Rodríguez A., Gómez-Sánchez E., Rico L., Heredia-Rodríguez M., Gómez-Pesquera E., Tamayo E. IL-1B rs16944 polymorphism is related to septic shock and death. Eur. J. Clin. Investig. 2017;47:53–62. doi: 10.1111/eci.12702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.12702</ArticleId><ArticleId IdType="pubmed">27859227</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasztelewicz B., Czech-Kowalska J., Lipka B., Milewska-Bobula B., Borszewska-Kornacka M., Romańska J., Dzierżanowska-Fangrat K. Cytokine gene polymorphism associations with congenital cytomegalovirus infection and sensorineural hearing loss. Eur. J. Clin. Microbiol. Infect. Dis. 2017;36:1811–1818. doi: 10.1007/s10096-017-2996-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-017-2996-6</ArticleId><ArticleId IdType="pmc">PMC5602083</ArticleId><ArticleId IdType="pubmed">28501927</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogo L.D., Rezaei F., Marashi S.M., Yekaninejad M.S., Naseri M., Ghavami N., Mokhtari-Azad T. Seasonal influenza A/H3N2 virus infection and IL-1Β, IL-10, IL-17, and IL-28 polymorphisms in Iranian population. J. Med. Virol. 2016;88:2078–2084. doi: 10.1002/jmv.24572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24572</ArticleId><ArticleId IdType="pubmed">27155288</ArticleId></ArticleIdList></Reference><Reference><Citation>Janahiraman S., Too C.L., Lee K.W., Shahril N.S., Leong C.O. Genetic biomarkers as predictors of response to tocilizumab in rheumatoid arthritis: A systematic review and meta-analysis. Genes. 2022;13:1284. doi: 10.3390/genes13071284.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes13071284</ArticleId><ArticleId IdType="pmc">PMC9323282</ArticleId><ArticleId IdType="pubmed">35886067</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Bai Y., Wang Y., Cui H., Tang M., Wang L., Wang X., Gu D. Cumulative evidence for associations between genetic variants in interleukin 6 receptor gene and human diseases and phenotypes. Front. Immunol. 2022;13:860703. doi: 10.3389/fimmu.2022.860703.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.860703</ArticleId><ArticleId IdType="pmc">PMC9046675</ArticleId><ArticleId IdType="pubmed">35493452</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi L., Rifai N., Hu F.B. Interleukin-6 receptor gene, plasma C-reactive protein, and diabetes risk in women. Diabetes. 2009;58:275–278. doi: 10.2337/db08-0968.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db08-0968</ArticleId><ArticleId IdType="pmc">PMC2606885</ArticleId><ArticleId IdType="pubmed">18852330</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbers C., Hermanns H.M., Schaper F., Müller-Newen G., Grötzinger J., Rose-John S., Scheller J. Plasticity and cross-talk of interleukin 6-type cytokines. Cytokine Growth Factor Rev. 2012;23:85–97. doi: 10.1016/j.cytogfr.2012.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2012.04.001</ArticleId><ArticleId IdType="pubmed">22595692</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihara M., Hashizume M., Yoshida H., Suzuki M., Shiina M. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin. Sci. 2012;122:143–159. doi: 10.1042/CS20110340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20110340</ArticleId><ArticleId IdType="pubmed">22029668</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodríguez-Hernández M.Á., Carneros D., Núñez-Núñez M., Coca R., Baena R., López-Ruiz G.M., Cano-Serrano M.E., Martínez-Tellería A., Fuentes-López A., Praena-Fernandez J.M. Identification of IL-6 signalling components as predictors of severity and outcome in COVID-19. Front. Immunol. 2022;13:891456. doi: 10.3389/fimmu.2022.891456.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.891456</ArticleId><ArticleId IdType="pmc">PMC9137400</ArticleId><ArticleId IdType="pubmed">35634332</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelsattar S., Kasemy Z., Ewida S., Abo-Elsoud R., Zytoon A., Abdelaal G., Abdelgawad A., Khalil F., Kamel H. ACE2 and TMPRSS2 SNPs as Determinants of Susceptibility to, and Severity of, a COVID-19 Infection. Br. J. Biomed. Sci. 2022;79:10238. doi: 10.3389/bjbs.2021.10238.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/bjbs.2021.10238</ArticleId><ArticleId IdType="pmc">PMC8915702</ArticleId><ArticleId IdType="pubmed">35996506</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai H.X., Hsieh B., Xiong Z., Halsey K., Choi J.W., Tran T.M.L., Pan I., Shi L.-B., Wang D.-C., Mei J. Performance of radiologists in differentiating COVID-19 from non-COVID-19 viral pneumonia at chest CT. Radiology. 2020;296:E46–E54. doi: 10.1148/radiol.2020200823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020200823</ArticleId><ArticleId IdType="pmc">PMC7233414</ArticleId><ArticleId IdType="pubmed">32155105</ArticleId></ArticleIdList></Reference><Reference><Citation>Zayed N.E., Abbas A., Lutfy S.M. Criteria and potential predictors of severity in patients with COVID-19. Egypt J. Bronchol. 2022;16:11. doi: 10.1186/s43168-022-00116-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43168-022-00116-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Song F., Shi N., Shan F., Zhang Z., Shen J., Lu H., Ling Y., Jiang Y., Shi Y. Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology. 2020;295:210–217. doi: 10.1148/radiol.2020200274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020200274</ArticleId><ArticleId IdType="pmc">PMC7233366</ArticleId><ArticleId IdType="pubmed">32027573</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Made C.I., Netea M.G., van der Veerdonk F.L., Hoischen A. Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19. Genome Med. 2022;14:96. doi: 10.1186/s13073-022-01100-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-022-01100-3</ArticleId><ArticleId IdType="pmc">PMC9390103</ArticleId><ArticleId IdType="pubmed">35986347</ArticleId></ArticleIdList></Reference><Reference><Citation>Alaa A., Sarhan N., Lotfy El-Ansary M.G., Bazan N.S., Farouk K., Ismail R.S., Schalaan M.F., Abd-Allah A.R. Association between genetic polymorphism, severity, and treatment response among COVID-19 infected Egyptian patients. Front. Pharmacol. 2023;14:1209286. doi: 10.3389/fphar.2023.1209286.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2023.1209286</ArticleId><ArticleId IdType="pmc">PMC10323191</ArticleId><ArticleId IdType="pubmed">37426824</ArticleId></ArticleIdList></Reference><Reference><Citation>Elgedawy G.A., Elabd N.S., Salem R.H., Awad S.M., Amer A.A., Torayah M.M., El-Koa A.A., Abozeid M., Montaser B.A., Aboshabaan H.S. FURIN, IFNL4, and TLR2 gene polymorphisms in relation to COVID-19 severity: A case–control study in Egyptian patients. Infection. 2024:1–17. doi: 10.1007/s15010-024-02266-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-024-02266-1</ArticleId><ArticleId IdType="pubmed">38703289</ArticleId></ArticleIdList></Reference><Reference><Citation>Elnagdy M.H., Magdy A., Eldars W., Elgamal M., El-Nagdy A.H., Salem O., Elmowafy M.M., Elborsh O.A., Elshafey A.W., Kesba M.M. Genetic association of ACE2 and TMPRSS2 polymorphisms with COVID-19 severity; a single centre study from Egypt. Virol. J. 2024;21:27. doi: 10.1186/s12985-024-02298-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-024-02298-x</ArticleId><ArticleId IdType="pmc">PMC10807154</ArticleId><ArticleId IdType="pubmed">38263160</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamilloux Y., Henry T., Belot A., Viel S., Fauter M., El Jammal T., Walzer T., François B., Sève P. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmun. Rev. 2020;19:102567. doi: 10.1016/j.autrev.2020.102567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102567</ArticleId><ArticleId IdType="pmc">PMC7196557</ArticleId><ArticleId IdType="pubmed">32376392</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavillegrand J.-R., Garnier M., Spaeth A., Mario N., Hariri G., Pilon A., Berti E., Fieux F., Thietart S., Urbina T. Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: Inflammatory response of SARS-CoV-2 patients. Ann. Intensive Care. 2021;11:9. doi: 10.1186/s13613-020-00798-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00798-x</ArticleId><ArticleId IdType="pmc">PMC7804215</ArticleId><ArticleId IdType="pubmed">33439360</ArticleId></ArticleIdList></Reference><Reference><Citation>Luan Y.-Y., Yin C.-H., Yao Y.-M. Update advances on C-reactive protein in COVID-19 and other viral infections. Front. Immunol. 2021;12:720363. doi: 10.3389/fimmu.2021.720363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.720363</ArticleId><ArticleId IdType="pmc">PMC8382792</ArticleId><ArticleId IdType="pubmed">34447386</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao M., Liu Y., Yuan J., Wen Y., Xu G., Zhao J., Cheng L., Li J., Wang X., Wang F. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 2020;26:842–844. doi: 10.1038/s41591-020-0901-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0901-9</ArticleId><ArticleId IdType="pubmed">32398875</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce N., Rhodes S., Stocking K., Pembrey L., van Veldhoven K., Brickley E.B., Robertson S., Davoren D., Nafilyan V., Windsor-Shellard B. Occupational differences in COVID-19 incidence, severity, and mortality in the United Kingdom: Available data and framework for analyses. Wellcome Open Res. 2021;6:102. doi: 10.12688/wellcomeopenres.16729.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.16729.1</ArticleId><ArticleId IdType="pmc">PMC8188261</ArticleId><ArticleId IdType="pubmed">34141900</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Liu C., Mao Z., Xiao M., Wang L., Qi S., Zhou F. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: A systematic review and meta-analysis. Crit. Care. 2020;24:647. doi: 10.1186/s13054-020-03374-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03374-8</ArticleId><ArticleId IdType="pmc">PMC7667659</ArticleId><ArticleId IdType="pubmed">33198786</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang A.-P., Liu J.-P., Tao W.-Q., Li H.-M. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int. Immunopharmacol. 2020;84:106504. doi: 10.1016/j.intimp.2020.106504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.106504</ArticleId><ArticleId IdType="pmc">PMC7152924</ArticleId><ArticleId IdType="pubmed">32304994</ArticleId></ArticleIdList></Reference><Reference><Citation>Toori K.U., Qureshi M.A., Chaudhry A., Safdar M.F. Neutrophil to lymphocyte ratio (NLR) in COVID-19: A cheap prognostic marker in a resource constraint setting. Pak. J. Med. Sci. 2021;37:1435. doi: 10.12669/pjms.37.5.4194.</Citation><ArticleIdList><ArticleId IdType="doi">10.12669/pjms.37.5.4194</ArticleId><ArticleId IdType="pmc">PMC8377926</ArticleId><ArticleId IdType="pubmed">34475926</ArticleId></ArticleIdList></Reference><Reference><Citation>Trofin F., Nastase E.V., Roșu M.F., Bădescu A.C., Buzilă E.R., Miftode E.G., Manciuc D.C., Dorneanu O.S. Inflammatory Response in COVID-19 Depending on the Severity of the Disease and the Vaccination Status. Int. J. Mol. Sci. 2023;24:8550. doi: 10.3390/ijms24108550.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24108550</ArticleId><ArticleId IdType="pmc">PMC10218522</ArticleId><ArticleId IdType="pubmed">37239895</ArticleId></ArticleIdList></Reference><Reference><Citation>Canevelli M., Palmieri L., Raparelli V., Punzo O., Donfrancesco C., Noce C.L., Vanacore N., Brusaferro S., Onder G. COVID-19 mortality among migrants living in Italy. Ann. Dell’istituto Super. Di Sanità. 2020;56:373–377.</Citation><ArticleIdList><ArticleId IdType="pubmed">32959804</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues F.B.B., da Silva R., Santos E.F.d., de Brito M.T.F.M., da Silva A.L.S., de Meira Leite M., Póvoa da Costa F., de Nazaré do Socorro de Almeida Viana M., de Sarges K.M.L., Cantanhede M.H.D. Association of polymorphisms of IL-6 pathway genes (IL6, IL6R and IL6ST) with COVID-19 severity in an Amazonian population. Viruses. 2023;15:1197. doi: 10.3390/v15051197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15051197</ArticleId><ArticleId IdType="pmc">PMC10220739</ArticleId><ArticleId IdType="pubmed">37243282</ArticleId></ArticleIdList></Reference><Reference><Citation>Revez J.A., Bain L., Chapman B., Powell J.E., Jansen R., Duffy D.L., Tung J.Y., Penninx B.W., Visscher P.M., De Geus E.J. A new regulatory variant in the interleukin-6 receptor gene associates with asthma risk. Genes Immun. 2013;14:441–446. doi: 10.1038/gene.2013.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gene.2013.38</ArticleId><ArticleId IdType="pmc">PMC4233139</ArticleId><ArticleId IdType="pubmed">23945879</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Hu H., Wu J., Zhao X., Zhen Y., Wang S., Li W., Liang M., Wu B., Ma G. The IL6R gene polymorphisms are associated with sIL-6R, IgE and lung function in Chinese patients with asthma. Genes. 2016;585:51–57. doi: 10.1016/j.gene.2016.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2016.03.026</ArticleId><ArticleId IdType="pubmed">26997259</ArticleId></ArticleIdList></Reference><Reference><Citation>Pairo-Castineira E., Clohisey S., Klaric L., Bretherick A.D., Rawlik K., Pasko D., Walker S., Parkinson N., Fourman M.H., Russell C.D. Genetic mechanisms of critical illness in COVID-19. Nature. 2021;591:92–98. doi: 10.1038/s41586-020-03065-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-03065-y</ArticleId><ArticleId IdType="pubmed">33307546</ArticleId></ArticleIdList></Reference><Reference><Citation>Investigators R.-C., Gordon A.C., Mouncey P.R., Al-Beidh F., Rowan K.M., Nichol A.D., Arabi Y.M., Annane D., Beane A., van Bentum-Puijk W. Interleukin-6 receptor antagonists in critically ill patients with COVID-19–preliminary report. MedRxiv. 2021;384:11491–11502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7953461</ArticleId><ArticleId IdType="pubmed">33631065</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw M., Collins B.F., Ho L.A., Raghu G. Rheumatoid arthritis-associated lung disease. Eur. Respir. Rev. 2015;24:1–16. doi: 10.1183/09059180.00008014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09059180.00008014</ArticleId><ArticleId IdType="pmc">PMC9487778</ArticleId><ArticleId IdType="pubmed">25726549</ArticleId></ArticleIdList></Reference><Reference><Citation>Balzanelli M.G., Distratis P., Lazzaro R., Pham V.H., Tran T.C., Dipalma G., Bianco A., Serlenga E.M., Aityan S.K., Pierangeli V. Analysis of gene single nucleotide polymorphisms in COVID-19 disease highlighting the susceptibility and the severity towards the infection. Diagnostics. 2022;12:2824. doi: 10.3390/diagnostics12112824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12112824</ArticleId><ArticleId IdType="pmc">PMC9689844</ArticleId><ArticleId IdType="pubmed">36428884</ArticleId></ArticleIdList></Reference><Reference><Citation>Abady N.R., Alkhafaji Z.A., Baay A.S. Polymorphisms in the inter leukin-1 beta gene (rs16944 and rs1143627) as a risk factor for SARS-CoV2 infection; Proceedings of the AIP Conference Proceedings; Banten, Indonesia. 30 September 2023.</Citation></Reference><Reference><Citation>García-Ramírez R.A., Ramírez-Venegas A., Quintana-Carrillo R., Camarena Á.E., Falfán-Valencia R., Mejía-Aranguré J.M. TNF, IL6, and IL1B polymorphisms are associated with severe influenza A (H1N1) virus infection in the Mexican population. PLoS ONE. 2015;10:e0144832. doi: 10.1371/journal.pone.0144832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0144832</ArticleId><ArticleId IdType="pmc">PMC4682834</ArticleId><ArticleId IdType="pubmed">26657940</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokhylko V., Cherniavska Y., Fishchuk L., Rossokha Z., Popova O., Vershyhora V., Ievseienkova O., Soloviova H., Zhuk L., Gorovenko N. Association of the C3953T (rs1143634) variant of the interleukin 1 beta gene with the features of a complicated course of COVID-19-associated pneumonia. Mol. Biol. Rep. 2024;51:630. doi: 10.1007/s11033-024-09569-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-024-09569-4</ArticleId><ArticleId IdType="pubmed">38720147</ArticleId></ArticleIdList></Reference><Reference><Citation>de Sá N.B.R., Neira-Goulart M., Ribeiro-Alves M., Perazzo H., Geraldo K.M., Ribeiro M.P.D., Cardoso S.W., Grinsztejn B., Veloso V.G., Capão A. Inflammasome Genetic Variants Are Associated with Protection to Clinical Severity of COVID-19 among Patients from Rio de Janeiro, Brazil. BioMed Res. Int. 2022;2022:9082455. doi: 10.1155/2022/9082455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/9082455</ArticleId><ArticleId IdType="pmc">PMC9467712</ArticleId><ArticleId IdType="pubmed">36105941</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulito-Cueto V., Sebastián Mora-Gil M., Ferrer-Pargada D., Remuzgo-Martínez S., Genre F., Lera-Gómez L., Alonso-Lecue P., Batista-Liz J.C., Tello-Mena S., Abascal-Bolado B. Inflammasome-Related Genetic Polymorphisms as Severity Biomarkers of COVID-19. Int. J. Mol. Sci. 2024;25:3731. doi: 10.3390/ijms25073731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25073731</ArticleId><ArticleId IdType="pmc">PMC11011752</ArticleId><ArticleId IdType="pubmed">38612539</ArticleId></ArticleIdList></Reference><Reference><Citation>Karcioglu Batur L., Hekim N. Correlation between interleukin gene polymorphisms and current prevalence and mortality rates due to novel coronavirus disease 2019 (COVID-2019) in 23 countries. J. Med. Virol. 2021;93:5853–5863. doi: 10.1002/jmv.27127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27127</ArticleId><ArticleId IdType="pmc">PMC8242628</ArticleId><ArticleId IdType="pubmed">34081354</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng J.W., Chong E.T., Lee P.-C. An Updated Review on the Role of Single Nucleotide Polymorphisms in COVID-19 Disease Severity: A Global Aspect. Curr. Pharm. Biotechnol. 2022;23:1596–1611.</Citation><ArticleIdList><ArticleId IdType="pubmed">35034591</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins A., Lonjou C., Morton N.E. Genetic epidemiology of single-nucleotide polymorphisms. Proc. Natl. Acad. Sci. USA. 1999;96:15173–15177. doi: 10.1073/pnas.96.26.15173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.26.15173</ArticleId><ArticleId IdType="pmc">PMC24792</ArticleId><ArticleId IdType="pubmed">10611357</ArticleId></ArticleIdList></Reference><Reference><Citation>Abecasis G.R., Cookson W.O. GOLD—graphical overview of linkage disequilibrium. Bioinformatics. 2000;16:182–183. doi: 10.1093/bioinformatics/16.2.182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/16.2.182</ArticleId><ArticleId IdType="pubmed">10842743</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>